PONATINIB EXPERIENCE IN A PEDIATRIC CHRONIC MYELOID LEUKEMIA PATIENT

Objective: Chronic myeloid leukemia (CML) is rarely seen in children. The development of myelofibrosis in CML is not uncommon and is associated with a poor prognosis. In cases unresponsive to treatment, tyrosine kinase mutation should be checked for drug resistance, second generation tyrosine kinase...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Serap Karaman, Mustafa Bilici, Ayşegül Ünüvar, Deniz Tuğcu, Gülşah Tanyıldız, Rumeysa Tuna Deveci, Gülçin Yegen, Şifa Şahin, Zeynep Karakaş
Format: article
Langue:EN
Publié: Elsevier 2021
Sujets:
Accès en ligne:https://doaj.org/article/a1adf842c03041b58f9bd8dd0082a76e
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!